Stanley Street Treatment and Resources

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 681 citations · Full text

Opioid Epidemic, Comparative Effectiveness, Substance Abuse +10

Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder

Michael D. Stein, Micah T. Conti, Shannon R. Kenney et al. · Drug and Alcohol Dependence · 2017 · 208 citations · Full text

Opioid Epidemic, Substance Abuse, Substance Use +14

Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification

Lisa A. Uebelacker, Genie L. Bailey, Debra S. Herman et al. · Journal of Substance Abuse Treatment · 2016 · 107 citations · Full text

Opioid Epidemic, Substance Use, Psychiatry +12

Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder

Michael Frost, Genie L. Bailey, Nicholas Lintzeris et al. · Addiction · 2019 · 103 citations · Full text

Dismantling Mindfulness-Based Cognitive Therapy: Creation and validation of 8-week focused attention and open monitoring interventions within a 3-armed randomized controlled trial

Willoughby B. Britton, Jake H. Davis, Eric B. Loucks et al. · Behaviour Research and Therapy · 2017 · 99 citations · Full text

Mindfulness-based Cognitive Therapy, Open Monitoring Interventions, Psychiatry +14